Dr. Bryce Litwin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 350 N 11th St, Sunbury, PA 17801 Phone: 570-286-3333 |
News Archive
Using gene chips to profile tumors before treatment, researchers at Harvard and Yale Universities found markers that identified breast cancer subtypes resistant to Herceptin, the primary treatment for HER2-positive breast cancer. They say this advance could help further refine therapy for the 25 to 30 percent of breast cancer patients with this class of tumor.
Research from life-saving charity Air Ambulance Kent Surrey Sussex in partnership with the University of Surrey has shown the benefits of dispatching HEMS to patients with a sudden, unexplained LOC of medical origin and a high prevalence of acute neurological pathology.
Determining whether or not an individual has dementia and to what degree is a long and laborious process that can take an experienced professional such as a clinician about four to five hours to administer, interpret and score the test results. A leading neuroscientist at Florida Atlantic University has developed a way for a layperson to do this in three to five minutes with results that are comparable to the "gold standard" dementia tests used by clinicians today.
"As a U.N. high-level panel completes worldwide consultations to pick development goals for 2015 and beyond, PlusNews consulted experts to see how HIV/AIDS might fit into this new agenda," according the news service.
› Verified 8 days ago